QQQ $ 602.61 $ 4.22 (0.71 %)
DIA $ 463.04 $ 0.00 (0 %)
SPY $ 665.11 $ 2.94 (0.44 %)
TLT $ 90.76 $ -0.20 (-0.22 %)
GLD $ 387.41 $ 6.60 (1.73 %)
$ 0.02
-- x --
-- x --
-- - --
$ 0.02 - $ 23.82
12,716
na
2.42M
$ 2.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-19-2024 09-30-2024 10-Q
2 08-08-2024 06-30-2024 10-Q
3 05-07-2024 03-31-2024 10-Q
4 03-29-2024 12-31-2023 10-K
5 11-14-2023 09-30-2023 10-Q
6 08-08-2023 06-30-2023 10-Q
7 05-10-2023 03-31-2023 10-Q
8 03-28-2023 12-31-2022 10-K
9 11-08-2022 09-30-2022 10-Q
10 08-09-2022 06-30-2022 10-Q
11 05-10-2022 03-31-2022 10-Q
12 03-07-2022 12-31-2021 10-K
13 11-15-2021 09-30-2021 10-Q
14 08-16-2021 06-30-2021 10-Q
15 05-18-2021 03-31-2021 10-Q
16 03-30-2021 12-31-2020 10-K
17 11-05-2020 09-30-2020 10-Q
18 07-31-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nyse-to-begin-delisting-proceedings-against-danimer-scientific

NYSE Regulation reached its decision to delist the Company's Class A common stock pursuant to Section 802.01B of the NYSE&#...

 danimer-scientific-q3-eps-018-beats-820-estimate-sales-863m-beat-858m-estimate

Danimer Scientific (NYSE:DNMR) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(8....

 danimer-scientific-announces-intention-to-complete-a-1-for-40-reverse-stock-split-expected-to-begin-trading-on-a-split-adjusted-basis-on-november-13-2024

Expected to Begin Trading on a 1-for-40 Reverse Split-Adjusted Basis on November 13, 2024Danimer Scientific, Inc. (NYSE:DNMR) (...

 danimer-scientific-announces-second-circuit-court-affirms-dismissal-of-class-action-lawsuit

Danimer Scientific, Inc. (NYSE:DNMR) ("Company" or "Danimer Scientific"), a leading next generation bioplastics...

 danimer-scientific-names-richard-altice-interim-ceo-preliminary-q3-pha-revenue-of-67m-increased-by-08m-compared-to-q2-2024-company-maintains-its-forecast-that-annualized-pha-revenues-will-more-than-triple-by-the-end-of-q2-2025

Current Board Member and Former CEO of NatureWorks to Lead Company While Board Continues Search Process for Permanent CEOCompan...

 piper-sandler-maintains-neutral-on-danimer-scientific-lowers-price-target-to-1

Piper Sandler analyst Charles Neivert maintains Danimer Scientific (NYSE:DNMR) with a Neutral and lowers the price target fr...

 td-cowen-downgrades-danimer-scientific-to-hold-lowers-price-target-to-1

TD Cowen analyst Thomas Boyes downgrades Danimer Scientific (NYSE:DNMR) from Buy to Hold and lowers the price target from $2...

 danimer-scientific-q2-2024-gaap-eps-019-beats-024-estimate-sales-7628m-miss-9270m-estimate

Danimer Scientific (NYSE:DNMR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0....

 jefferies-downgrades-danimer-scientific-to-hold-lowers-price-target-to-08

Jefferies analyst Laurence Alexander downgrades Danimer Scientific (NYSE:DNMR) from Buy to Hold and lowers the price target ...

 danimer-scientifics-ceo-and-chairman-steve-croskrey-announces-retirement-to-step-down-as-ceo-no-later-than-the-end-of-this-calendar-year-to-exit-chairman-position-may-20-2024-board-appoints-richard-j-hendrix-as-interim-ceo-and-new-co-chairman

Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics compan...

 danimer-scientific-q1-2024-gaap-eps-026-beats-031-estimate-sales-10224m-miss-11063m-estimate

Danimer Scientific (NYSE:DNMR) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION